Results 101 to 110 of about 1,825,523 (203)

Impediments to Progress Toward Polio Eradication During 2014–2024: Effectively Addressing the Current Challenges

open access: yesVaccines
When the Global Polio Eradication Initiative (GPEI) began in 1988, the year 2000 target was clearly ambitious. Nonetheless, among 20 countries with endemic wild poliovirus transmission in 2000, only Afghanistan, Nigeria and Pakistan remained endemic in ...
Steven G. F. Wassilak   +2 more
doaj   +1 more source

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency

open access: yesPathogens
A sharp rise in circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in the years following the cessation of routine use of poliovirus type 2-containing oral polio vaccine and the trend of seeding new emergences with suboptimal vaccination ...
Feyrouz Damji Kurji   +9 more
doaj   +1 more source

Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation. [PDF]

open access: yesGates Open Res, 2023
Kalkowska DA   +6 more
europepmc   +1 more source

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children. [PDF]

open access: yesJ Infect Dis, 2022
Tagbo BN   +16 more
europepmc   +1 more source

Emerg Infect Dis

open access: yes
Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine.

core  

Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine. [PDF]

open access: yesVaccines (Basel), 2022
Manukyan H   +7 more
europepmc   +1 more source

National inventory for poliovirus containment : minimizing risk of poliovirus release from laboratories in the United States [PDF]

open access: yes
The US Poliovirus National Authority for Containment of Poliovirus (NAC), located in the Centers for Disease Control and Prevention, Center for Preparedness and Response, appreciates your participation in this survey.

core  

Immune persistence after different polio sequential immunization schedules in Chinese infants

open access: yesnpj Vaccines
Trivalent oral poliovirus vaccine (tOPV) has been withdrawn and instead an inactivated poliovirus vaccine (IPV) and bivalent type 1 and type 3 OPV (bOPV) sequential immunization schedule has been implemented since 2016, but no immune persistence data are
Ting Zhao   +33 more
doaj   +1 more source

Home - About - Disclaimer - Privacy